Section Arrow
VNRX.NYSE-M
- VolitionRX Limited
Quotes are at least 15-min delayed:2025/02/03 17:31 EST
Last
 0.596
+0.001 (+0.17%)
Day High 
0.599 
Prev. Close
0.595 
1-M High
0.69 
Volume 
80.59K 
Bid
0.58
Ask
0.61
Day Low
0.575 
Open
0.58 
1-M Low
0.5667 
Market Cap 
57.10M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.61 
20-SMA 0.63 
50-SMA 0.64 
52-W High 1.23 
52-W Low 0.4301 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.36/-0.31
Enterprise Value
61.50M
Balance Sheet
Book Value Per Share
-0.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
775.30K
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.8951-0.0657-6.84%-- 
PACBPacific Biosciences of California1.46-0.08-5.19%-- 
QSIQuantum-Si1.82-0.16-8.08%-- 
BSXBoston Scientific Corp103.07+0.71+0.69%84.6PE
MDTMedtronic plc90.53-0.29-0.32%27.96PE
Quotes are at least 15-min delayed:2025/02/03 17:31 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.